Literature DB >> 11856595

High-dose chemotherapy with autologous stem cell rescue for brain tumors.

Ira J Dunkel1, Jonathan L Finlay.   

Abstract

The use of high-dose chemotherapy with stem cell rescue for malignant brain tumors is reviewed. Promising results have been reported in patients with medulloblastomas, supratentorial PNET's and high-grade astrocytomas. Results thus far have been disappointing for ependymomas and brain stem gliomas. The role of this treatment strategy for other chemotherapy-sensitive tumors such as oligodendrogliomas and central nervous system germ cell tumors has yet to be determined.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11856595     DOI： 10.1016/s1040-8428(01)00156-1

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


  12 in total

Review 1.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

2.  High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

Authors:  Antonio Pérez-Martínez; Alvaro Lassaletta; Marta González-Vicent; Julián Sevilla; Miguel Angel Díaz; Luis Madero
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA.

Authors:  Eduard H Panosyan; Alan K Ikeda; Vivian Y Chang; Dan R Laks; Charles L Reeb; La Vette Bowles; Joseph L Lasky; Theodore B Moore
Journal:  J Transplant       Date:  2011-04-14

4.  Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.

Authors:  David S Ziegler; Richard J Cohn; Geoffrey McCowage; Frank Alvaro; Cecilia Oswald; Robert Mrongovius; Les White
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

5.  High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors.

Authors:  Antonio Pérez-Martínez; Victor Quintero; Marta González Vicent; Julián Sevilla; Miguel Angel Díaz; Luis Madero
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 6.  The adolescent and young adult with cancer: state of the art--brain tumor.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 7.  Medulloblastomas and central nervous system primitive neuroectodermal tumors.

Authors:  Thomas W McLean
Journal:  Curr Treat Options Oncol       Date:  2003-12

8.  Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Authors:  J A Guerra; G Dhall; A Marachelian; E Castillo; J Malvar; K Wong; R Sposto; J L Finlay
Journal:  Bone Marrow Transplant       Date:  2017-08-07       Impact factor: 5.483

Review 9.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

Review 10.  Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view.

Authors:  Jan Vesper; B Bölke; C Wille; P A Gerber; C Matuschek; M Peiper; H J Steiger; W Budach; G Lammering
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.